Chromatin/Epigenetics(染色质/表观遗传学)
Epigenetics
Epigenetics means above genetics. It determines how much and whether a gene is expressed without changing DNA sequences. Epigenetic regulations include, 1. DNA methylation: the addition of methyl group to DNA, converting cytosine to 5-methylcytosine, mostly at CpG sites; 2. Histone modifications: posttranslational modificationEpigeneticss of histone proteins including acetylation, methylation, ubiquitylation, phosphorylation and sumoylation; 3. miRNAs: non-coding microRNA downregulating gene expression; 4. Prions: infectious proteins viewed as epigenetic agents capable of inducing a phenotype without changing the genome.
Products for Chromatin/Epigenetics
- Bromodomain(47)
- Aurora Kinase(57)
- DNA Methyltransferase(32)
- HDAC(176)
- Histone Acetyltransferases(71)
- Histone Demethylases(99)
- Histone Methyltransferase(204)
- HIF(91)
- JAK(154)
- MBT Domains(1)
- PARP(104)
- Pim(27)
- Protein Ser/Thr Phosphatases(31)
- RNA Polymerase(6)
- Sirtuin(70)
- Sphingosine Kinase-2(1)
- Polycomb repressive complex(2)
- SUMOylation(3)
- PAD(21)
- Epigenetic Reader Domain(205)
- MicroRNA(20)
- Chromodomain(1)
- Citrullination(20)
- DNA/RNA Demethylation(2)
- DNA/RNA Methylation(8)
- Histone Deacetylation(42)
- Histones/Histone Peptides(62)
- PHD Domains(1)
- Tandem Tudor & Tudor-like Domains(1)
- PRMT(2)
- Readers(1)
- Cat.No. 产品名称 Information
-
GC10148
RN 1 dihydrochloride
LSD1 Inhibitor IV
An irreversible LSD1 inhibitor -
GC17118
GSK J5
N-[2-(3-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸乙酯
A negative control compound for GSK-J4 -
GC13086
GSK J2
N-[2-(3-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸
A negative control compound for GSK-J1 - GC13187 I-BET 151 hydrochloride A BRD2, BRD3, and BRD4 inhibitor
-
GC17754
IOX 1
5-羰基-8-羟基喹啉
A 2-oxoglutarate oxygenase inhibitor -
GC14249
UNC 0642
2-(4,4-二氟-1-哌啶基)-6-甲氧基-N-[1-异丙基-4-哌啶基]-7-[3-(1-吡咯烷基)丙氧基]-4-喹唑啉胺
A G9a histone methyltransferase inhibitor -
GC15731
L002
p300/CBP Inhibitor VI, NSC 764414
A p300 acetyltransferase inhibitor -
GC15104
(R)-(+)-Etomoxir sodium salt
(R)-(+)-乙莫克舍钠盐,(R)-(+)-Etomoxir sodium salt
(R)-(+)-Etomoxir sodium salt(Etomoxir; ETO)是一种用于代谢和心血管疾病的小分子,经酶转化为活性抑制剂乙托莫西里尔辅酶a (IC50 约为0.01-0.70 µM)后,对CPT-1a和CPT-1b的抑制表现出纳摩尔效价。 - GC14817 Salermide A sirtuin inhibitor
-
GC17881
AGK 2
2-氰基-3-[5-(2,5-二氯苯基)-2-呋喃基]-N-5-喹啉基-2-丙烯酰胺
AGK2是一种选择性的SIRT2 抑制剂,IC50为3.5 µM。 - GC12934 YM 750 YM 750 是一种有效的 acyl-CoA:cholesterol acyltransferase (ACAT) 抑制剂 (IC50\u003d0.18 μM)。
- GC10931 VULM 1457 VULM 1457 是一种有效的胆固醇酰基转移酶 (acyl-CoA) 抑制剂。
-
GC11539
CI 976
CI 976
An inhibitor of ACAT-1 -
GC11561
NSC 95397
Cdc25 Inhibitor IV, PTP Inhibitor XXIX
An irreversible inhibitor of Cdc25 isoforms - GC16130 C 21 Protein arginine methyltransferase 1 (PRMT1) inhibitor
-
GC17672
TC-E 5003
N,N'-[磺酰基二(4,1-亚苯基)]二(2-氯乙酰胺)
A PRMT1 inhibitor -
GC14361
PFI 3
(2E)-1-(2-羟基苯基)-3-[(1R,4R)-5-(2-吡啶基)-2,5-二氮杂双环[2.2.1]庚-2-基]-2-丙烯-1-酮
Probe for bromodomains of SMARCA2/4 and PB1(bromodomain 5) -
GC11340
(R)-PFI 2 hydrochloride
(R)-PFI-2 hydrochloride
A SET7/9 inhibitor -
GC13919
Tranylcypromine hydrochloride
反苯环丙胺盐酸盐,SKF 385 hydrochloride
An irreversible, mechanism-based inhibitor of LSD1 -
GC11381
Tautomycetin
Tautomycetin 是一种有效的特异性 PP1 抑制剂,具有潜在的细胞凋亡诱导活性。
-
GC12359
Hispidulin
高车前素; Dinatin
A flavonoid with diverse biological activities -
GC14875
NSC 663284
DA-3003-1
Inhibitor of Cdc25 isoforms -
GC10676
AK-7
N-(3-溴苯基)-3-[(六氢-1H-氮杂卓-1-基)磺酰基]-苯甲酰胺
An inhibitor of SIRT2 - GC16599 CPI-169 A selective EZH2 inhibitor
- GC13926 BMS-345541(free base) BMS-345541(free base) 是 IKK 催化亚基的选择性抑制剂 (IKK-2 IC50=0.3 μM, IKK-1 IC50=4 μM)。 BMS-345541(游离碱)结合在 IKK 的变构位点。
-
GC12667
4SC-202
4SC-202(盐的形式),4SC-202
An HDAC1-3 and KDM1A inhibitor - GC13764 Nexturastat A A potent, cell-permeable HDAC6 inhibitor
-
GC12917
Acetaminophen
对乙酰氨基酚; Paracetamol; 4-Acetamidophenol; 4'-Hydroxyacetanilide
An analgesic and antipyretic compound
-
GC10243
Nanaomycin C
七尾霉素C
Amide of nanaomycin A
-
GC14066
Procaine
普鲁卡因
An Analytical Reference Standard - GC17052 MK-4827 Racemate selective inhibitor of PARP1/PARP2
-
GC11767
Hydralazine HCl
盐酸肼屈嗪
An antihypertensive agent -
GC15857
Sodium butyrate
丁酸钠
A short-chain fatty acid and HDAC inhibitor -
GC11576
Tranylcypromine (2-PCPA) HCl
(1S,2R)-2-苯基-环丙胺盐酸盐,(1S,2R)-SKF 385 hydrochloride
(1S,2R)-Tranylcypromine ((1S,2R)-SKF 385) hydrochloride 是一种有效的抗抑郁剂。 - GC17314 OG-L002 An LSD1 inhibitor
- GC15259 EPZ004777 HCl EPZ004777 HCl 是一种有效的选择性 DOT1L 抑制剂,IC50 为 0.4 nM。
- GC12733 C646 C646是一种有效的选择性p300/CBP组蛋白乙酰转移酶抑制剂(Ki 400 nM),已被证明具有多效性,包括神经保护、抗癌和抗上皮间质转化(anti-EMT)作用。
-
GC15410
Bufexamac
丁苯羟酸; Bufexamic acid
An NSAID and a class IIb HDAC inhibitor -
GC16290
Nafamostat hydrochloride
盐酸萘莫司他
Nafamostat hydrochloride 是一种合成丝氨酸蛋白酶抑制剂,是一种抗凝剂。 -
GC17676
Nafamostat
萘莫司他
A serine protease inhibitor -
GC14490
Donepezil HCl
盐酸多奈哌齐; E2020
An AChE inhibitor -
GC12579
GLPG0634
非戈替尼,GLPG0634
A JAK1 inhibitor -
GC10154
ABC294640
3-(4-氯苯基)-N-(4-吡啶基甲基)金刚烷-1-甲酰胺,ABC294640
An inhibitor of SPHK2 - GC14699 CPI-203 A bioavailable inhibitor of BET bromodomains
- GC12698 BAY 87-2243 A mitochondrial complex I inhibitor and inducer of ferroptosis
-
GC14756
EI1
6-氰基-N-[(1,2-二氢-4,6-二甲基-2-氧代-3-吡啶基)甲基]-1-(1-乙基丙基)-1H-吲哚-4-甲酰胺,KB-145943
A selective inhibitor of EZH2 - GC14151 CBB1007 CBB1007 是一种细胞可渗透的脒基胍化合物,可作为一种有效的、可逆的和底物竞争性 LSD1 选择性抑制剂(hLSD1 的 IC50 = 5.27 μM)。
-
GC13103
AZ505 ditrifluoroacetate
N-环己基-3-[[2-(3,4-二氯苯基)乙基]氨基]-N-[2-[[2-(3,4-二氢-5-羟基-3-氧代-2H-1,4-苯并恶嗪-8-基)乙基]氨基]乙基]丙酰胺二(2,2,2-三氟乙酸盐)
An inhibitor of SMYD2 -
GC13744
AZ505
N-环己基-3-(3,4-二氯苯乙基氨基)-N-[2-[[2-[5-羟基-3-氧代-3,4-二氢-2H-苯并[B][1,4]恶嗪-8-基]乙基]氨基]乙基]丙酰胺
An inhibitor of SMYD2 -
GC14063
GSK1324726A
I-BET726
A selective inhibitor of BET family proteins